GSK1016790A   Click here for help

GtoPdb Ligand ID: 4205

PDB Ligand
Compound class: Synthetic organic
Comment: GSK1016790A is an activator (agonist) of the transient receptor potential cation channel, TRPV4.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 3
Rotatable bonds 13
Topological polar surface area 172.74
Molecular weight 654.11
XLogP 3.5
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(C(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc2c(s1)cccc2)CC(C)C)NS(=O)(=O)c1ccc(cc1Cl)Cl
Isomeric SMILES OC[C@@H](C(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc2c(s1)cccc2)CC(C)C)NS(=O)(=O)c1ccc(cc1Cl)Cl
InChI InChI=1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1
InChI Key IVYQPSHHYIAUFO-VXKWHMMOSA-N
Bioactivity Comments
GSK1016790A inhibits TNF-α-induced monocyte adhesion to human endothelial cells. In vivo, GSK1016790A reduces atherosclerotic plaque formation in ApoE deficient mice, indicative of a potential for TRPV4 activation to be used as a therapeutic approach to treat atherosclerosis [3].
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
TRPV4 Hs Activator Activation 8.7 pEC50 - 1
pEC50 8.7 (EC50 2.1x10-9 M) [1]
Voltage: Physiological
TRPV4 Rn Activator Activation 8.0 pEC50 - 2
pEC50 8.0 [2]
Voltage: Physiological
TRPV4 Mm Activator Activation 7.7 pEC50 - 1
pEC50 7.7 [1]
Voltage: Physiological